Please note a recent eligibility update for this Johnson & Johnson implementation science opportunity. Community cancer centers are no longer explicitly listed as eligible applicants, though they remain the target audience for these initiatives. Additionally, your proposal's outcomes assessment must now align with Moore’s framework.
Funder: Johnson & Johnson (Janssen)
Due Dates: June 30, 2026
Funding Amounts: Up to $275,000 per project; lower-cost projects prioritized; max project duration 18 months
Summary: Supports implementation science educational initiatives to improve care for relapsed/refractory multiple myeloma patients, focusing on integrating evidence-based practices in community settings.
Key Information: General research projects are not eligible; only implementation science projects with embedded education are considered.